Abstract | OBJECTIVE: DESIGN: Retrospective study. METHOD: PATIENTS: RESULTS: CONCLUSION:
Lercanidipine frequently causes chyloperitoneum in Taiwanese PD patients. The risk of developing this adverse event seems to be related to the blood lipid profile. The mechanism of this phenomenon is worthy of further investigation.
|
Authors | Wei-Shun Yang, Jenq-Wen Huang, Huei-Wen Chen, Tun-Jun Tsai, Kwan-Dun Wu |
Journal | Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
(Perit Dial Int)
2008 Nov-Dec
Vol. 28
Issue 6
Pg. 632-6
ISSN: 0896-8608 [Print] United States |
PMID | 18981394
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antihypertensive Agents
- Dihydropyridines
- Triglycerides
- lercanidipine
|
Topics |
- Adult
- Antihypertensive Agents
(adverse effects)
- Ascites
(metabolism)
- Chylous Ascites
(chemically induced)
- Comorbidity
- Cross-Sectional Studies
- Dihydropyridines
(adverse effects)
- Female
- Humans
- Hypertension
(epidemiology)
- Kidney Failure, Chronic
(epidemiology, therapy)
- Male
- Middle Aged
- Peritoneal Dialysis
- Retrospective Studies
- Triglycerides
(blood)
|